The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Gyenes Lawrence A since year 2005.
The trader's CIK number is 1301629.
At the time of this reporting, Gyenes Lawrence A is the SVP, Chief Financial of Columbia Laboratories Inc .
(stock ticker symbol CBRX).
See this page for all insider trading activities at Columbia Laboratories Inc .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2009-11-09||CBRX||Columbia Laboratories Inc||Buy||50,000||.87||43,300|
|2005-05-17||SVNT||Savient Pharmaceuticals Inc||Buy||15,000||3.08||46,125|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Gyenes Lawrence A (SVP, Chief Financial of Columbia Laboratories Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.